{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Apremilast+Tablet&page=2", "query": { "intervention": "Apremilast Tablet", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Apremilast+Tablet&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-20T05:20:38.495Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03747939", "title": "Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Arthritis, Psoriatic" ], "interventions": [ { "name": "Apremilast (CC-10004)", "type": "DRUG" }, { "name": "Apremilast (CC-10004) Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 310, "start_date": "2018-12-31", "completion_date": "2023-07-05", "has_results": true, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-09-20T05:20:38.495Z", "location_count": 54, "location_summary": "Mesa, Arizona • Covina, California • Encino, California + 48 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Covina", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03747939" }, { "nct_id": "NCT03000309", "title": "Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "Apremilast", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Derm Research, PLLC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2016-12-29", "completion_date": "2018-04-25", "has_results": true, "last_update_posted_date": "2019-03-28", "last_synced_at": "2026-09-20T05:20:38.495Z", "location_count": 1, "location_summary": "Louisville, Kentucky", "locations": [ { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT03000309" }, { "nct_id": "NCT01925768", "title": "Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Apremilast 30 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 219, "start_date": "2013-09-04", "completion_date": "2016-11-17", "has_results": true, "last_update_posted_date": "2020-05-12", "last_synced_at": "2026-09-20T05:20:38.495Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Palm Desert, California • Brandon, Florida + 20 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Palm Desert", "state": "California" }, { "city": "Brandon", "state": "Florida" }, { "city": "Brandon", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01925768" }, { "nct_id": "NCT06588738", "title": "A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "Envudeucitinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Apremilast", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alumis Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 862, "start_date": "2024-08-20", "completion_date": "2025-12-18", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-09-20T05:20:38.495Z", "location_count": 43, "location_summary": "Birmingham, Alabama • Chandler, Arizona • Tucson, Arizona + 36 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Encino", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06588738" }, { "nct_id": "NCT01172938", "title": "Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Apremilast 20mg", "type": "DRUG" }, { "name": "Apremilast 30mg", "type": "DRUG" }, { "name": "Placebo + 20 mg Apremilast", "type": "DRUG" }, { "name": "Placebo + 30 mg Apremilast", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 504, "start_date": "2010-06-02", "completion_date": "2016-10-27", "has_results": true, "last_update_posted_date": "2020-06-19", "last_synced_at": "2026-09-20T05:20:38.495Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • La Jolla, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01172938" }, { "nct_id": "NCT06586112", "title": "A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "Envudeucitinib", "type": "DRUG" }, { "name": "Apremilast", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alumis Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 912, "start_date": "2024-07-25", "completion_date": "2025-11-20", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-09-20T05:20:38.495Z", "location_count": 55, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Rogers, Arkansas + 49 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Chula Vista", "state": "California" }, { "city": "Encinitas", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06586112" }, { "nct_id": "NCT04908475", "title": "Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "Risankizumab", "type": "DRUG" }, { "name": "Apremilast", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 352, "start_date": "2021-06-09", "completion_date": "2023-04-20", "has_results": true, "last_update_posted_date": "2024-04-30", "last_synced_at": "2026-09-20T05:20:38.495Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Phoenix, Arizona + 22 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sacramento", "state": "California" }, { "city": "Coral Gables", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04908475" }, { "nct_id": "NCT01041625", "title": "Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lichen Planus" ], "interventions": [ { "name": "Apremilast (CC-10004)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Virginia Clinical Research, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2010-02", "completion_date": "2012-02", "has_results": false, "last_update_posted_date": "2010-01-01", "last_synced_at": "2026-09-20T05:20:38.495Z", "location_count": 1, "location_summary": "Norfolk, Virginia", "locations": [ { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01041625" }, { "nct_id": "NCT01212757", "title": "PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Apremilast 20mg", "type": "DRUG" }, { "name": "Apremilast 30mg", "type": "DRUG" }, { "name": "Placebo + 20 mg Apremilast", "type": "DRUG" }, { "name": "Placebo + 30 mg Apremilast", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 488, "start_date": "2010-09-27", "completion_date": "2017-01-25", "has_results": true, "last_update_posted_date": "2020-05-06", "last_synced_at": "2026-09-20T05:20:38.495Z", "location_count": 23, "location_summary": "Tuscaloosa, Alabama • Denver, Colorado • Trumbull, Connecticut + 18 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Denver", "state": "Colorado" }, { "city": "Trumbull", "state": "Connecticut" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01212757" }, { "nct_id": "NCT02236988", "title": "Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Apremilast Immediate Release", "type": "DRUG" }, { "name": "Apremilast Modified Release 1", "type": "DRUG" }, { "name": "Apremilast Modified Release 2", "type": "DRUG" }, { "name": "Apremilast Modified Release 3", "type": "DRUG" }, { "name": "Apremilast Modified Release 4", "type": "DRUG" }, { "name": "Apremilast Modified Release 5", "type": "DRUG" }, { "name": "Apremilast Modified Release 6", "type": "DRUG" }, { "name": "Apremilast Modified Release 8", "type": "DRUG" }, { "name": "Apremilast Modified Release 9", "type": "DRUG" }, { "name": "Apremilast Modified Release 11", "type": "DRUG" }, { "name": "Apremilast Modified Release 12", "type": "DRUG" }, { "name": "Apremilast Modified Release 13", "type": "DRUG" }, { "name": "Apremilast Modified Release 14", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 80, "start_date": "2014-01-07", "completion_date": "2014-09-11", "has_results": true, "last_update_posted_date": "2021-06-01", "last_synced_at": "2026-09-20T05:20:38.495Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT02236988" } ] }